These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2559 related items for PubMed ID: 19950803

  • 1. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 2. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R, Wang B, Ding H, Shen H, Li Y, Chen X.
    Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
    [Abstract] [Full Text] [Related]

  • 4. Anti-p53 autoantibodies in hepatitis C virus-infected patients.
    Raedle J, Oremek G, Roth WK, Caspary WF, Zeuzem S.
    Anticancer Res; 1997 Jan; 17(4B):3079-81. PubMed ID: 9329606
    [Abstract] [Full Text] [Related]

  • 5. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
    Mukozu T, Nagai H, Matsui D, Kanekawa T, Sumino Y.
    Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
    [Abstract] [Full Text] [Related]

  • 6. Serum P53 Abs in HCC patients with viral hepatitis - type C.
    EI-Emshaty HM, Gadelhak SA, Abdelaziz MM, Abbas AT, Gadelhak NA.
    Hepatogastroenterology; 2014 Sep; 61(134):1688-95. PubMed ID: 25436364
    [Abstract] [Full Text] [Related]

  • 7. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K, Watanabe T, Aikawa K, Toshima M, Shibasaki K, Aoyagi Y.
    Hepatogastroenterology; 1998 Sep; 45(23):1737-41. PubMed ID: 9840138
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P, Chanmee T, Komtong S, Mahachai V, Wisedopas N, Pothacharoen P, Kongtawelert P.
    J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
    [Abstract] [Full Text] [Related]

  • 9. Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and alpha-fetoprotein.
    Corradini SG, Morini S, Liguori F, Carotti S, Muda AO, Burza MA, Siciliano M, Molinaro A, Cantafora A, Blotta I, Merli M, Berloco P, Rossi M, Attili AF, Gaudio E.
    Liver Int; 2009 Jan; 29(1):103-12. PubMed ID: 18544126
    [Abstract] [Full Text] [Related]

  • 10. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
    Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Benvegnù L, Calabrese F, Gatta A, Pontisso P, Fassina G.
    Cancer; 2005 Jun 15; 103(12):2558-65. PubMed ID: 15887222
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T.
    Int J Mol Med; 2002 Mar 15; 9(3):245-50. PubMed ID: 11836630
    [Abstract] [Full Text] [Related]

  • 15. [Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma].
    Jia HL, Xing XJ, Ye QH, Qin LX.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug 15; 30(4):440-3. PubMed ID: 18795617
    [Abstract] [Full Text] [Related]

  • 16. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L.
    J Gastroenterol Hepatol; 2009 Jan 15; 24(1):55-62. PubMed ID: 18823443
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L, Wu XH.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 15; 5(4):538-44. PubMed ID: 17085339
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
    Sacco R, Leuci D, Tortorella C, Fiore G, Marinosci F, Schiraldi O, Antonaci S.
    Cytokine; 2000 Jun 15; 12(6):811-4. PubMed ID: 10843770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 128.